IRIS
MOROZZI, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.622
EU - Europa 5.279
AS - Asia 2.879
SA - Sud America 421
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 69
OC - Oceania 10
AN - Antartide 1
Totale 17.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.511
CN - Cina 1.059
RU - Federazione Russa 980
GB - Regno Unito 936
SG - Singapore 928
IT - Italia 845
IE - Irlanda 654
UA - Ucraina 440
SE - Svezia 418
BR - Brasile 347
DE - Germania 340
FR - Francia 316
VN - Vietnam 221
HK - Hong Kong 210
FI - Finlandia 164
KR - Corea 140
BD - Bangladesh 73
IN - India 73
CA - Canada 64
ES - Italia 42
NL - Olanda 42
ZA - Sudafrica 34
CI - Costa d'Avorio 26
IQ - Iraq 26
TR - Turchia 26
BE - Belgio 25
AR - Argentina 22
MX - Messico 21
JP - Giappone 18
PL - Polonia 18
CO - Colombia 15
NG - Nigeria 14
CZ - Repubblica Ceca 13
ID - Indonesia 13
PK - Pakistan 12
SA - Arabia Saudita 12
AT - Austria 11
EC - Ecuador 11
VE - Venezuela 10
IR - Iran 9
MA - Marocco 8
AU - Australia 7
MY - Malesia 7
EU - Europa 6
GR - Grecia 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
EG - Egitto 5
NP - Nepal 5
PH - Filippine 5
TN - Tunisia 5
UZ - Uzbekistan 5
CH - Svizzera 4
IL - Israele 4
JM - Giamaica 4
LT - Lituania 4
PE - Perù 4
RO - Romania 4
UY - Uruguay 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
KE - Kenya 3
OM - Oman 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
QA - Qatar 2
RW - Ruanda 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IM - Isola di Man 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
Totale 17.313
Salva come PNG Salva come JPEG
Città #
Menlo Park 1.653
Southend 804
Dallas 758
Dublin 641
Ashburn 597
Singapore 564
Fairfield 528
Chandler 400
Jacksonville 352
Santa Clara 352
San Jose 349
Moscow 272
Woodbridge 271
Beijing 262
Ann Arbor 231
Wilmington 220
Seattle 216
Hong Kong 203
Cambridge 181
Houston 179
Milan 178
The Dalles 138
New York 137
Hefei 136
Seoul 123
Princeton 120
Council Bluffs 118
Nanjing 118
Rome 104
Siena 96
Los Angeles 93
Ho Chi Minh City 78
Munich 64
Helsinki 60
San Diego 59
Lauterbourg 58
Boardman 53
Nanchang 48
San Mateo 41
Buffalo 40
Hanoi 40
Dearborn 35
Columbus 33
São Paulo 32
Turku 31
Johannesburg 29
Shanghai 29
Shenyang 29
Hebei 27
Toronto 27
Abidjan 26
Brussels 24
Figino 23
San Francisco 23
Tianjin 22
Chicago 21
Frankfurt am Main 21
Kunming 21
Málaga 21
Orem 21
Brooklyn 19
Chennai 19
London 19
Venezia 19
Falls Church 18
Boston 16
Changsha 16
Düsseldorf 16
Guangzhou 16
Jiaxing 16
Jinan 16
Montreal 16
Denver 15
Dong Ket 15
Turin 15
Zhengzhou 15
Atlanta 14
Bengaluru 14
Phoenix 14
Tokyo 14
Warsaw 14
Abuja 13
Lancaster 13
Mestre 12
Ningbo 12
Redondo Beach 12
Baghdad 11
Da Nang 11
Washington 11
Brno 10
Florence 10
Mexico City 10
Mumbai 10
Rio de Janeiro 10
Stockholm 10
Amsterdam 9
Ankara 9
Belo Horizonte 9
Charlotte 9
Philadelphia 9
Totale 11.966
Salva come PNG Salva come JPEG
Nome #
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 490
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 434
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 428
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study 384
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 373
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 326
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 320
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 318
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 314
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 303
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 302
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 301
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 285
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 282
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study 276
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 273
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 272
Anomalie cromosomiche, valutate come frequenza di micronuclei spontanei, in soggetti con fenomeno di Raynaud sospetto presclerodermico [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon] 266
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 263
Antinuclear Human Autoantibodies as Markers in Nicotiana Tabacum Pollen Tubes 261
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 260
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 259
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 255
Chromosome aberrations in Raynaud's phenomenon 253
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 252
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies 250
Poly(ADP-ribose) polymerase activity in systemic lupus erythematosus and systemic sclerosis. 247
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 246
Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis 245
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 244
Comportamento delle purine plasmatiche e urinarie dopo dieta apurinica in soggetti normali e gottosi 242
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohoert of SLE patients 237
Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? 237
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 237
Esame del liquido sinoviale 228
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 220
Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis 218
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 215
Clearance of oxypurines and uric acid in gouty patients [Clearance delle ossipurine e dell'acido urico in soggetti gottosi] 214
Ruolo degli autoanticorpi nella diagnosi della colangite sclerosante primitiva 213
Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis 213
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 212
Thiopurine methyltransferase activity in the erythrocytes of adults and children: and HPLC-linked assay 212
Allelic variations of DPB1, DQA1, DQB1 and DRB1 and rheumatoid arthritis: further genetic and statistical considerations [Varianti alleliche dei DPB1, DQA1, DQB1, DRB1 e artite reumatoide: ulteriori considerazioni genetiche e statistiche] 210
Serologic profile and mortality rates of scleroderma renal crisis in Italy 209
Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) 205
L'elettroforesi bidimensionale su gel di poliacrilamide nello studio dei profili proteici sierici nell'artrite reumatoide 204
Epidemiologic study about hyperuricemia's prevalence on an unselected champion of subjects, in a village of Siena's province 202
Usefulness of the determination of C reactive protein and other acute phase proteins in rheumatoid arthritis [Utilità del dosaggio della proteina C reattiva e di altre proteine della fase acuta nell'artrite reumatoide] 199
Modification of DNA patterns in plasma and nucleated blood cells from systemic sclerosis patients 198
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 196
Semeiotica di laboratorio delle malattie reumatiche 193
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature 185
Lessons from the "Euro-Lupus Cohort" 184
Evaluation of the clinical therapeutic response to oral gold salts in patients with rheumatoid arthritis 184
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 180
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 177
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 176
HSP70-1 promoter region polymorphism tested in three autoimmune diseases 176
Comparison of different methods for the detection ofanti-Ro/SSA antibodies in connective tissue diseases 169
Immunogenetics of the antiphospholipid syndrome 168
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 166
Human serum recognizes components of plant cells: New research perspectives [Sieri umani riconoscono componenti di cellule vegetali: Nuove prospettive di ricerca] 165
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies 163
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus : correlation with clinical and autoantibody subsets 161
Is two dimensional polyacrilamide gel electrophoresis a usful technique for the study of serum protein profiles in rheumatoid arthritis 154
Effect of local corticosteroid injection in carpal tunnel syndrome: Clinical and electrophysiological aspects [Efficacia del trattamento con cortisonoci nella sindrome del tunnel carpale idiopatica: studio clinico e neurofisiologico] 151
Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Revision 2015 142
Lesch-Nyhan syndrome: Observations on a clinical case [La sindrome di Lesch-Nyhan: osservazione di un caso clinico] 135
In vitro study on the possible inflammatory mechanism of ferrous ions: effect on the production of oxygen free radicals [Studi in vitro sul possibile meccanismo flogogeno degli ioni ferro: azione sulla produzione di radicali liberi dell'ossigeno] 133
Immunogenetics of systemic lupus erythematosus: The contribution of DRB3 and DQB1 alleles [Immunogenetica del lupus eritematoso sistemico: il ruolo degli alleli DRB3 e DQB1] 123
PARP activity and NAD concentration in PMC from patients affected by systemic sclerosis and lupus erythematosus 121
The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. 119
null 117
null 89
null 69
Il test ANA-reflex.The ANA-reflex test. 69
Antibodies to the lens and cornea in anti-DFS70-positive subjects 6
A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases. 4
Rheumatoid factor isotypes in patients with erosive osteoarthritis of the hand. 3
Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni. 2
Totale 17.387
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.483
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 51 108 39 20 41 38 31 102 73 227
2022/20231.406 86 122 203 205 146 270 16 117 145 25 56 15
2023/20241.062 41 22 86 93 41 299 336 24 12 9 11 88
2024/20252.029 35 112 174 102 301 109 44 122 190 79 243 518
2025/20264.983 390 689 556 543 1.030 249 509 89 138 234 103 453
2026/2027759 182 309 268 0 0 0 0 0 0 0 0 0
Totale 17.387